The May 2026 edition of Shaping Business is now out. The thread running through it is this: every business featured was built before the conditions fully existed to build it.

Dr. Katie King and Dr. Leonor Teles are manufacturing cancer drugs in low-Earth orbit, where microgravity produces protein crystals impossible to grow on the ground. Their April 2026 seed round is claimed to be the largest ever raised for an in-space manufacturing business.

Valentina Milanova built a diagnostic tampon that screens for high-risk HPV without a clinic appointment, won the Digital Health Rewired Pitchfest and secured a potential NHS pilot pathway - before the UK government launched a £1.5 million FemTech Challenge Fund the following month.

Ana Martins crossed £1 million in annual revenue and secured Morrisons and Ocado listings before Froot Pops had taken a single pound from an outside investor.

Sophie Neall turned down the only investor who said yes to Good Kynd because the relationship wasn't right.

These are not stories about being backed. They're stories about what happens before that.

The funding question is addressed directly. In May 2026, Arāya Ventures announced the first close of its Sie Fund at £7.5 million, a vehicle specifically structured to back female-led technology startups in the UK and Europe, backed by British Business Investments and managed by Rupa Popat.

The issue also includes Cavendish's Beauty & Wellness M&A report - with a message that applies well beyond the sector. The market has buyers. It doesn't have enough businesses that meet the bar.